Pair Name | Periplocin, TNF-related apoptosis inducing ligand | ||
Phytochemical Name | Periplocin (PubChem CID: 14463159 ) | ||
Anticancer drug Name | TNF-related apoptosis inducing ligand (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Periplocin, TNF-related apoptosis inducing ligand | |||
Disease Info | [ICD-11: 2B70.1] | Esophageal squamous cell carcinoma | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BIRC5 | hsa332 |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP8 | hsa841 | |
Down-regulation | Activity | CTNNB1 | hsa1499 | |
Down-regulation | Phosphorylation | CTNNB1 | hsa1499 | |
Down-regulation | Activity | FOXP3 | hsa50943 | |
Up-regulation | Expression | TNFRSF10A | hsa8797 | |
Up-regulation | Expression | TNFRSF10B | hsa8795 | |
In Vitro Model | Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_6898 |
TE-1 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_1759 | |
YES-2 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_E322 | |
KYSE-30 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_1351 | |
KYSE-410 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_1352 | |
KYSE-510 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_1354 | |
Result | Our data suggest that CPP and TRAIL could be further explored as potential therapeutic approach for esophageal cancer. |
Pair Name | Periplocin, TNF-related apoptosis inducing ligand | |||
Disease Info | [ICD-11: 2B72] | Gastric cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Down-regulation | Expression | BID | hsa637 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Expression | CASP8 | hsa841 | |
Up-regulation | Expression | EGR1 | hsa1958 | |
Up-regulation | Phosphorylation | MAPK1 | hsa5594 | |
Down-regulation | Expression | MCL1 | hsa4170 | |
Up-regulation | Expression | TNFRSF10A | hsa8797 | |
Up-regulation | Expression | TNFRSF10B | hsa8795 | |
In Vivo Model | The proceduresusing animals were approved by the Animal Care and Use Committee.SGC-7901 cells (1×10⁵/100μL/mouse) were suspended in 0.9%physiological saline and subcutaneously injected into the right flank ofeach mouse. | |||
Result | Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway |
No. | Title | Href |
---|---|---|
1 | Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. J Exp Clin Cancer Res. 2019 Dec 21;38(1):501. doi: 10.1186/s13046-019-1498-z. | Click |
2 | Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway. Mol Carcinog. 2019 Jun;58(6):1033-1045. doi: 10.1002/mc.22991. | Click |